Stockholder alert: the m&a class action firm announces the investigation of chembio diagnostics, inc. - cemi

New york , feb. 1, 2023 /prnewswire/ -- juan monteverde , founder and managing partner of the class action firm monteverde & associates pc (the "m&a class action firm"), a national securities firm rated top 50 in the 2018-2021 iss securities class action services report and headquartered at the empire state building in new york city, is investigating chembio diagnostics, inc. (nasdaq: cemi), relating to its proposed sale to biosynex sa. under the terms of the agreement, cemi shareholders are expected to receive $0.45 in cash per share they own.
CEMI Ratings Summary
CEMI Quant Ranking